
Mary M McDermott MD
Jeremiah Stamler Professor of Medicine, Northwestern University Medical School
Join to View Full Profile
675 N Saint Clair StSuite 18-200Chicago, IL 60611
Phone+1 312-695-8630
Dr. McDermott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mary McDermott is an internist in Chicago, IL and is affiliated with Northwestern Memorial Hospital. She received her medical degree from Michigan State University College of Human Medicine and has been in practice 28 years. She is experienced in deputy editor, jama and jeremiah stamler professor of medicine. She has more than 300 publications and an H index of 97.
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1989 - 1993
Michigan State University College of Human MedicineClass of 1989
YaleBA, 1981 - 1985
Certifications & Licensure
IL State Medical License 1991 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Clinical Research Award American Heart Association, 2023
- Distinguished Achievement Award American Heart Association Peripheral Vascular Disease Council, 2022
- John M. Eisenberg Award for Research Achievement Society of General Internal Medicine, 2021
- Join now to see all
Clinical Trials
- Blood Factors and Peripheral Arterial Disease Outcomes Start of enrollment: 2001 Jan 01
- Reducing Risk Factors in Peripheral Arterial Disease Start of enrollment: 2006 Feb 01
- Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD) Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial.Yi Lin, Rola S Zeidan, Stephanie Lapierre-Nguyen, Hannah M Costello, Stephen D Anton
Geroscience. 2025-12-01 - Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial.Mary M McDermott, Kathryn J Domanchuk, Lu Tian, Lihui Zhao, Dongxue Zhang
JAMA. 2025-11-08 - Gastrocnemius Myofiber Type and Mitochondrial Alterations Associated With Peripheral Artery Disease Severity.Kate Kosmac, Rena Dana Wang, Jada Stewart, Parminder Kaur, Ahmed Ismaeel
Function. 2025-10-28
Journal Articles
- The Enabling Reduction of Low-Grade Inflammation in Seniors (ENRGISE) Pilot Study: Screening Methods and Recruitment ResultsAnne B Newman, Marco Pahor, Mary M McDermott, The Journals of Gerontology
Lectures
- Panelist: Exercise Therapy in PAD Opportunities and Practical Tips2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Shark Tank Pitch 12019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Use of a Wearable Activity Monitor in a Home-Based Exercise Intervention for Peripheral Artery Disease—ReplyAmerican Heart Association, Scientific Sessions 2013, Dallas, Texas, USA
- Join now to see all
Press Mentions
JAMA at AHA, Review of MASLD, Primary Biliary Cholangitis, and MoreNovember 14th, 2025
Metformin Does Not Improve Walking in Peripheral Artery Disease Without DiabetesNovember 14th, 2025
Testing Metformin’s Reach in PADNovember 11th, 2025- Join now to see all
Grant Support
- IMProving mobility After revasCularizaTion in Peripheral Artery Disease: the IMPACT PAD TrialNORTHWESTERN UNIVERSITY AT CHICAGO2024–2031
- Response to Exercise and Nitric Oxide in PAD: the RESIST PAD TrialNORTHWESTERN UNIVERSITY AT CHICAGO2023–2028
- BEET root juice to reverse functional impairment in PAD: The BEET PAD TrialNORTHWESTERN UNIVERSITY AT CHICAGO2022–2027
- Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PADNORTHWESTERN UNIVERSITY AT CHICAGO2022–2027
- COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II TrialNORTHWESTERN UNIVERSITY AT CHICAGO2021–2026
- 1/2 + PROmote weight loss in obese PAD patients to preVEnt mobility loss: the PROVE TrialNORTHWESTERN UNIVERSITY AT CHICAGO2019–2026
- IMProving mobility After revasCularizaTion in Peripheral Artery Disease: the IMPACT PAD TrialNORTHWESTERN UNIVERSITY AT CHICAGO2024–2025
- ENhancing exercise with LIGHT to improve functioning in PAD: the ENLIGHTEN PAD TrialNORTHWESTERN UNIVERSITY AT CHICAGO2023–2025
- Far Red Light to Improve Functioning in PAD: the LIGHT PAD TrialNORTHWESTERN UNIVERSITY AT CHICAGO2023–2025
- FIsetin to Reduce Senescence and mobility impairmenT in PAD: the FIRST Pilot Randomized TrialNORTHWESTERN UNIVERSITY AT CHICAGO2022–2025
- INTERmittent pneumatic ComprEssion for Disability rEversal in PAD: the INTERCEDE TrialNORTHWESTERN UNIVERSITY AT CHICAGO2018–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









